Brian Kelly, PhD, CLP is the Director of Cornell Center for Technology Enterprise and Commercialization and oversees the technology transfer division serving the Weill Cornell Medical College.  He manages a portfolio of inventions including pharmaceuticals, molecular diagnostics, neural stem cells, gene therapy compositions and methods, and medical devices.Kelly has more than ten years experience in technology licensing both in the United States and Europe, and has successfully negotiated more than 200 license agreements and has been involved in the formation of approximately twenty start-up companies and is a certified licensing professional.   Kelly holds a B.S. in Chemistry and a Ph.D. in Organic Chemistry from the University of Leicester. 
 

Return to Life Science 50